Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | CNR1 | P21554 | 5/20 | 0.48 |
| ▸ | CNR2 | P34972 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SELP | P16109 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24826063 | 0.88 | CNR1 (0.52) | ALDH1A1CNR1CNR2LMNAPKM | |
| SCHEMBL11452609 | 0.86 | ALDH1A1 (0.61) | ALDH1A1CNR1LMNAPKMGAA | |
| SCHEMBL3835164 | 0.85 | ALDH1A1 (0.80) | ALDH1A1CNR1CNR2GAANAAA | |
| SCHEMBL19199205 | 0.84 | CNR1 (0.57) | ALDH1A1CNR1CNR2LMNAPKM | |
| SCHEMBL309291 | 0.84 | CNR1 (0.57) | ALDH1A1CNR1CNR2LMNAPKM | |
| SCHEMBL27997036 | 0.84 | CNR1 (0.57) | ALDH1A1CNR1CNR2LMNAPKM | |
| SCHEMBL26733411 | 0.83 | ALDH1A1 (0.52) | ALDH1A1CNR1CNR2LMNAPKM | |
| SCHEMBL1518045 | 0.83 | ALDH1A1 (0.57) | ALDH1A1CNR1LMNAPKMGAA | |
| SCHEMBL16248615 | 0.83 | ALDH1A1 (0.57) | ALDH1A1CNR1CNR2LMNAPKM | |
| SCHEMBL25746265 | 0.83 | ALDH1A1 (0.57) | ALDH1A1CNR1LMNAPKMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3833662-B1 | INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION | JANSSEN PHARMACEUTICA NV (BE) | 2024-01-17 | — | — | EP | disclosed |
| US-20230357158-A1 | QUINOLINE cGAS ANTAGONIST COMPOUNDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2023-11-09 | — | — | US | disclosed |
| WO-2023168367-A1 | QUINOLINE cGAS ANTAGONIST COMPOUNDS | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| US-10993931-B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | ALLERGAN, INC. (US) | 2021-05-04 | — | — | US | disclosed |
| WO-2021046307-A1 | HYBRIDIZED POLY(AMIDOAMINE)-AMINO ACID DENDRIMERS | NORTH CAROLINA STATE UNIVERSITY (US) | 2021-03-11 | — | — | WO | disclosed |
| US-20200399226-A1 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Grünenthal GmbH (DE) | 2020-12-24 | — | — | US | disclosed |
| US-20200331864-A1 | 1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES | GRUNENTHAL GMBH (DE) | 2020-10-22 | — | — | US | disclosed |
| US-10793528-B2 | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | Grünenthal GmbH (DE) | 2020-10-06 | — | — | US | disclosed |
| US-20190343804-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | ALLERGAN, INC. | 2019-11-14 | — | — | US | disclosed |
| US-20190100497-A1 | 3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | Grünenthal GmbH (DE) | 2019-04-04 | — | — | US | disclosed |
| US-20160235711-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | ALLERGAN, INC. | 2016-08-18 | — | — | US | disclosed |
| EP-2949665-A1 | GLYCOSYLATION ATRIAL NATRIURETIC PEPTIDE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-8993780-B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | ALLERGAN, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| WO-2014115797-A1 | GLYCOSYLATION ATRIAL NATRIURETIC PEPTIDE | 第一三共株式会社 (JP) | 2014-07-31 | — | — | WO | disclosed |
| US-20130078351-A1 | COMPOUNDS AND METHODS FOR ENHANCING SALTY TASTE | MONELL CHEMICAL SENSES CENTER (US) | 2013-03-28 | — | — | US | disclosed |
| US-20130078351-A1 | COMPOUNDS AND METHODS FOR ENHANCING SALTY TASTE | MONELL CHEMICAL SENSES CENTER (US) | 2013-03-28 | — | — | US | disclosed |
| US-20130078351-A1 | COMPOUNDS AND METHODS FOR ENHANCING SALTY TASTE | MONELL CHEMICAL SENSES CENTER (US) | 2013-03-28 | — | — | US | disclosed |
| EP-2531048-A1 | COMPOUNDS AND METHODS FOR ENHANCING SALTY TASTE | Monell Chemical Senses Center (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2011097344-A1 | COMPOUNDS AND METHODS FOR ENHANCING SALTY TASTE | MONELL CHEMICAL SENSES CENTER (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011097344-A1 | COMPOUNDS AND METHODS FOR ENHANCING SALTY TASTE | MONELL CHEMICAL SENSES CENTER (US) | 2011-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331864-A1 | 1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES | OPRK1, OPRD1, OPRL1 | ALDH1A1 32/4885CNR1 9/4885CNR2 14/4885 |
| US-20190343804-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | FPR1, FPR3, FPR2 | ALDH1A1 4424/4885CNR1 124/4885CNR2 282/4885 |
| US-20230357158-A1 | QUINOLINE cGAS ANTAGONIST COMPOUNDS | CGAS, GLS2, GLS | ALDH1A1 4236/4885CNR1 889/4885CNR2 565/4885 |
| US-10993931-B2 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | FPR1, FPR3, FPR2 | ALDH1A1 4424/4885CNR1 124/4885CNR2 282/4885 |
| US-20200399226-A1 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | OPRK1, OPRD1, OPRL1 | ALDH1A1 437/4885CNR1 11/4885CNR2 6/4885 |
| US-20160235711-A1 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | FPR1, FPR3, FPR2 | ALDH1A1 4424/4885CNR1 124/4885CNR2 282/4885 |
| US-20190100497-A1 | 3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | OPRK1, OPRD1, PKD2 | ALDH1A1 317/4885CNR1 12/4885CNR2 11/4885 |
| US-10793528-B2 | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | OPRK1, OPRD1, OPRL1 | ALDH1A1 437/4885CNR1 11/4885CNR2 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.